Transdermal Drug Delivery System: An Update of Upcoming Evolution
Author(s) -
Hemanavyatha Gunisetty,
Pavan Kumar Balagani
Publication year - 2016
Publication title -
journal of comprehensive pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2349-5669
DOI - 10.37483/jcp.2016.3104
Subject(s) - transdermal , drug , drug delivery , medicine , pharmacology , nanotechnology , materials science
In recent years considerable attention has been focused on the development of controlled release drug delivery systems. Controlled release drug delivery systems are designed to release one or more drugs continuously in a predetermined pattern for a fixed period of time either systemically or to a specified target organ. Drug release from this system should be at a desired predictable and reproducible rate. The primary objectives of controlled release drug delivery are to ensure safety and to improve efficacy of drugs as well as patient compliance. Controlled release drug delivery systems have been designed for oral parental, implantable and transdermal route. The benefits of intravenous infusion closely duplicated, without its hazards by using the skin as the port of drug administration to provide continuous transdermal drug infusion into the systemic circulation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom